Ask AI
SERENA 6
SERENA-6: Phase III Trial of ctDNA-Guided Switch to Camizestrant + CDK4/6i vs Continued AI + CDK4/6i Following ESR1 Mutation Emergence in HR+/HER2- Advanced Breast Cancer

Released: June 03, 2025

Expiration: December 02, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: June 03, 2025

Expiration: December 02, 2025